News · Fitness & Exercise
Sitting tracked with liver disease, not just heart disease
A Medicine & Science in Sports & Exercise study of 86,746 UK Biobank participants wearing accelerometers linked sedentary time to higher rates of chronic liver disease and liver-related death.
Based on a peer-reviewed cohort study in Medicine & Science in Sports & Exercise
- Researchers used 86,746 UK Biobank participants with accelerometer-measured movement over a full 24-hour day, publishing in Medicine & Science in Sports & Exercise.
- Movement was measured by device rather than self-report, which removes the biggest weakness in this kind of research.
- Per standard deviation more moderate-to-vigorous activity, hazard ratios were 0.74 for chronic liver disease, 0.68 for fatty liver disease, 0.81 for cirrhosis and 0.77 for liver-related death.
- Per standard deviation more sedentary time, the hazard ratio for liver-related death was 1.27, the largest of any outcome measured.
- Statistically reallocating time from other behaviors to moderate-to-vigorous activity was associated with lower risk.
- Blood proteins linked to activity accounted for about 18.2% of the activity-liver disease association; metabolites accounted for about 3.0%.
- It is observational. Early liver disease can itself make people less active, which would produce this pattern in reverse.
The case against sitting is usually made with hearts and blood sugar. The liver rarely gets mentioned, which is odd, because the most common chronic liver disease on earth is a storage problem.
A study in Medicine & Science in Sports & Exercise put numbers on it. Using 86,746 UK Biobank participants with accelerometer-measured 24h movement behaviors, the researchers estimated associations with chronic liver disease incidence and liver-related mortality.
What is new about measuring the whole day
Most activity research asks people how much they exercise. People are unreliable narrators about it. This study used devices instead, which is the change that makes the rest worth reading.
The other shift is treating the day as a closed budget. A day has 24 hours. Sleep, sitting, light movement and hard effort all compete for the same block. Studying one in isolation quietly assumes the others hold still. This analysis aimed to investigate the associations of 24-hour movement behaviors with chronic liver disease incidence and liver-related mortality as a set rather than one at a time.
What harder effort tracked with
The activity findings run in one direction across four different liver outcomes.
Moderate-to-vigorous physical activity was inversely associated with liver-related risks, with hazard ratios per standard deviation increase of 0.74 for chronic liver disease, 0.68 for metabolic-associated fatty liver disease, 0.81 for cirrhosis, and 0.77 for liver-related mortality.
Fatty liver disease showed the strongest association and cirrhosis the weakest, which fits how the disease progresses. Early fat accumulation is the reversible stage, driven by metabolism. Cirrhosis is scarring. By then alcohol, hepatitis and genetics carry more weight than a step count.
What sitting tracked with
The sedentary side is the part that earns the headline.
Sedentary behavior was associated with higher risks of incident chronic liver disease, fatty liver disease, cirrhosis, and liver-related mortality, with the strongest association for liver-related death.
The largest number in the study attaches to dying of liver disease, not to being diagnosed with it. That could mean sitting matters most at the severe end. It could equally mean people already dying of liver disease sit down a lot. The design cannot answer which.
The part where the day is a budget
Because the behaviors share a fixed 24 hours, the researchers modeled swaps. Reallocating time from other behaviors to moderate-to-vigorous activity was associated with lower risks of chronic liver disease incidence and liver-related mortality.
Nobody actually changed their routine. This is arithmetic on observed data, projecting what the association implies if time moved. Read as a projection it informs. Read as a promise it oversells.
A partial look inside the mechanism
The study also went after the pathway. Multi-omics analysis identified distinct proteomic and metabolic signatures for each behavior, with the activity-related protein signature potentially accounting for 18.2% and the metabolic signature 3.0% of the association between activity and chronic liver disease risk.
Twenty-one percent between them. The rest runs through something these blood measures did not capture. That is more honest than a clean mechanistic story. Finding a signature is not the same as explaining a link.
What this cannot show
It is observational, and the reverse-direction problem is serious here. Liver disease produces fatigue years before diagnosis. A cohort that finds inactive people getting liver disease may be watching early liver disease make people inactive.
The authors keep their conclusion inside the design: a higher proportion of moderate-to-vigorous activity and a lower proportion of sedentary behavior over a 24-hour period was associated with lower risks of chronic liver disease incidence and liver-related mortality.
What the study adds is the organ. Most people have absorbed that sitting is bad for the heart. Far fewer connect a sedentary day to the liver. Given how many people now have fat quietly accumulating in theirs, that is the useful part.
People also ask
Why would sitting affect the liver?
Fat storage. Metabolic-associated fatty liver disease, the most common chronic liver condition, develops when the liver accumulates fat it cannot clear, and that process is driven by the same insulin resistance and energy imbalance that inactivity promotes. Muscle contraction also draws glucose and fat out of circulation, so time spent not contracting muscle leaves more of both for the liver to deal with. The mechanism is plausible; this study measures the association rather than demonstrating the chain.
What does 'per standard deviation' mean here?
It is a way of expressing effect size when the exposure has no natural unit. Rather than asking what one extra minute does, the researchers ask what a typical spread of difference does, comparing someone fairly active with someone fairly inactive within this population. A hazard ratio of 0.74 per standard deviation means roughly a quarter lower rate across that gap. It is convenient and it makes the numbers harder to translate into a personal target.
How much of this is just reverse causation?
Some of it, almost certainly, and the study cannot say how much. Liver disease causes fatigue long before it is diagnosed, so people in the early stages move less because they are unwell. That would create exactly the association reported. Cohorts usually address this by excluding early cases, and the honest position is that this design cannot separate the two directions.
What did the protein and metabolite analysis add?
It gives a partial mechanism rather than a black box. The researchers identified blood signatures associated with each behavior and asked how much of the activity-liver link ran through them. The protein signature potentially accounted for 18.2% and the metabolite signature 3.0%. That leaves the large majority unexplained, which is honest but also means the pathway is mostly still unknown.
Is 'reallocating time' a real finding or a statistical exercise?
A statistical exercise, and a useful one. Because a day has a fixed 24 hours, adding activity necessarily removes something else, so studying behaviors in isolation is misleading. Reallocation models estimate what the data imply if time moved from one bucket to another. Nobody in the study actually changed their routine, so it projects an association rather than measuring an intervention.
References
- Zhang C, Huang M, Tang J, et al. Associations of 24-Hour Accelerometer-Measured Movement Behaviors with Chronic Liver Disease and the Mediating Role of Proteomics and Metabolomics. Medicine & Science in Sports & Exercise (2026).
- National Institute of Diabetes and Digestive and Kidney Diseases. Nonalcoholic Fatty Liver Disease & NASH.
- World Health Organization. Physical activity.